SPRUCE BIOSCIENCES INC (SPRB) Stock Analyst Ratings
NASDAQ:SPRB - Nasdaq - US85209E1091 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 50% to SPRB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.87. This target is 345.23% above the current price.
SPRB was analyzed by 10 analysts. The buy percentage consensus is at 50. So analysts seem to be rather neutral about SPRB.
In the previous month the buy percentage consensus was at a similar level.
SPRB was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-16 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-12-12 | Guggenheim | Reiterate | Neutral -> Neutral |
| 2024-12-11 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2024-12-11 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2024-12-11 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-11-12 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-08-19 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-08-13 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-06-13 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-06-05 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-05-14 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-03-14 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-03-14 | Ladenburg Thalmann | Downgrade | Buy -> Neutral |
| 2024-03-14 | Guggenheim | Downgrade | Buy -> Neutral |
| 2024-03-14 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-03-14 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2024-03-14 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-03-05 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-02-26 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-02-21 | Guggenheim | Initiate | Buy |
| 2023-11-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-13 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-09-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-08 | SVB Leerink | Upgrade | Market Perform -> Outperform |
| 2023-08-18 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-08-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-16 | JMP Securities | Maintains | Outperform -> Outperform |
| 2023-08-15 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-06-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-23 | Oppenheimer | Reiterate | Outperform -> Outperform |